Correlation Between Enhabit and Adaptimmune Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enhabit and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enhabit and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enhabit and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Enhabit and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enhabit with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enhabit and Adaptimmune Therapeutics.
Diversification Opportunities for Enhabit and Adaptimmune Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enhabit and Adaptimmune is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Enhabit and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Enhabit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enhabit are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Enhabit i.e., Enhabit and Adaptimmune Therapeutics go up and down completely randomly.
Pair Corralation between Enhabit and Adaptimmune Therapeutics
Given the investment horizon of 90 days Enhabit is expected to generate 0.78 times more return on investment than Adaptimmune Therapeutics. However, Enhabit is 1.28 times less risky than Adaptimmune Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Adaptimmune Therapeutics Plc is currently generating about -0.4 per unit of risk. If you would invest 843.00 in Enhabit on December 10, 2024 and sell it today you would earn a total of 24.00 from holding Enhabit or generate 2.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enhabit vs. Adaptimmune Therapeutics Plc
Performance |
| Timeline |
| Enhabit |
| Adaptimmune Therapeutics |
Enhabit and Adaptimmune Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enhabit and Adaptimmune Therapeutics
The main advantage of trading using opposite Enhabit and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enhabit position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.| Enhabit vs. The Ensign Group | ||
| Enhabit vs. Pennant Group | ||
| Enhabit vs. InnovAge Holding Corp | ||
| Enhabit vs. National HealthCare |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |